This is an outdated version published on 2026-01-31. Read the most recent version.


Vol. 3 No. 1 (2026)

Research Articles

A Analysis on Prevalence and Risk Factors of Chronic Kidney Disease in Yongzhou Region

Published 2026-01-31

  • Xiaoqiang Chen
    • ,
  • Lin Li
    • ,
  • Peng Wang
    • ,
  • Xiangjun Luo
    • ,
  • Xiaohua Deng
    • ,
  • Xueqing Liu
    • ,
  • Haixia Liu

Xiaoqiang Chen
Department of Clinical Laboratory, Yongzhou Central Hospital, Yongzhou 425002, China

Lin Li
Department of Clinical Laboratory, Yongzhou Central Hospital, Yongzhou 425002, China

Peng Wang
Department of Clinical Laboratory, Yongzhou Central Hospital, Yongzhou 425002, China

Xiangjun Luo
Department of Clinical Laboratory, Yongzhou Central Hospital, Yongzhou 425002, China

Xiaohua Deng
Department of Nephrology, Yongzhou Central Hospital, Yongzhou 425002, China

Xueqing Liu
Department of Clinical Laboratory, Yongzhou Central Hospital, Yongzhou 425002, China

Haixia Liu
Department of Clinical Laboratory, Yongzhou Central Hospital, Yongzhou 425002, China

Abstract

Objective This study is to investigate the prevalence of chronic kidney disease (CKD) and its major risk factors among the adult population in Yongzhou, Hunan Province, it provides a scientific basis for developing targeted CKD prevention and management strategies in this region.

Methods A cross-sectional study was conducted from January 2024 to July 2025, involving participants from the nephrology outpatient clinic and health check-up center of Yongzhou Central Hospital. All participants underwent questionnaires, physical examinations, and laboratory tests. The collected data were statistically analyzed.

Results A total of 2,571 eligible participants were enrolled in this study. The participants comprised 1,167 patients from the nephrology outpatient clinic and 1,404 individuals from the health examination center, with a mean age of 52.16 ± 14.23 years (50.36 ± 15.82 years for males and 54.09 ± 12.18 years for females). Chi-square tests revealed that the differences in the prevalence of CKD across groups stratified by age, BMI, physical labor level, alcohol consumption, hypertension, diabetes, dyslipidemia, and hyperuricemia were statistically significant in the total population. Logistic regression analysis identified increasing age, lack of physical labor, hypertension, diabetes, dyslipidemia, and hyperuricemia as independent risk factors for CKD.

Conclusion Although the prevalence of CKD among adults in Yongzhou is slightly lower than the national average, the absolute disease burden remains substantial and is closely associated with multiple modifiable metabolic risk factors. Early screening and comprehensive management of risk factors such as hypertension, diabetes, obesity, and hyperuricemia should be strengthened to delay the onset and progression of CKD.

Keywords

Chronic Kidney Disease, Prevalence, Risk Factors, Cross-Sectional Study

PDF

References

  1. Evans M, Lewis RD, Morgan AR, et al. A Narrative Review of Chronic Kidney Disease in Clinical Practice: Current Challenges and Future Perspectives. Adv Ther, 2022, 39(1): 33-43.
  2. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet, 2020, 395(10225): 709-33.
  3. Wang L, Xu X, Zhang M, et al. Prevalence of Chronic Kidney Disease in China: Results From the Sixth China Chronic Disease and Risk Factor Surveillance. JAMA Intern Med, 2023, 183(4): 298-310.
  4. Chinese Hypertension Prevention and Treatment Guidelines Revision Committee, Hypertension Alliance, Hypertension Branch of China Association for International Exchange and Promotion of Healthcare, etc Chinese Guidelines for the Prevention and Treatment of Hypertension (Revised 2024 Edition). Chinese Journal of Hypertension (in Chinese and English), 2024, 32(07): 603-700.
  5. Joint Expert Committee on Revision of Chinese Blood Lipid Management Guidelines Chinese Blood Lipid Management Guidelines (Grassroots Edition 2024). Chinese Journal of Cardiovascular Disease, 2024, 52 (4): 330-7.
  6. Stevens PE, Ahmed SB, Carrero JJ, et al. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International, 2024, 105(4): S117-S314.
  7. Ying M, Shao X, Qin H, et al. Disease Burden and Epidemiological Trends of Chronic Kidney Disease at the Global, Regional, National Levels from 1990 to 2019. Nephron, 2024, 148(2): 113-23.
  8. Ruiz-orteag M, Rayego-Mateos S, Lamas S, et al. Targeting the progression of chronic kidney disease. Nat Rev Nephrol, 2020, 16(5): 269-88.
  9. Mariampillai JE, HalvorsenL V, Larstorpa, et al. [Diabetes and chronic kidney disease]. Tidsskr Nor Laegeforen, 2023, 143(12).
  10. Goptaa, Nagaraju SP, Bhojaraja V, et al. Hypertension in Chronic Kidney Disease: An Update on Diagnosis and Management. South Med J, 2023, 116(2): 237-44.
  11. Wong LY, Liew AST, Weng WT, et al. Projecting the Burden of Chronic Kidney Disease in a Developed Country and Its Implications on Public Health. Int J Nephrol, 2018, 2018: 5196285.
  12. Zhou XY, Gong WW, Pan J, et al. Research on the Trend of Burden and Risk Factor Attribution of Chronic Kidney Disease in Zhejiang Province from 1990 to 2021. Chinese Journal of Chronic Disease Prevention and Control, 2025, 33 (07): 509-14
  13. Zhou XY, Gong WW, Pan J, etc Research on the Trend of Burden and Risk Factor Attribution of Chronic Kidney Disease in Zhejiang Province from 1990 to 2021 [J]. Prevention and Control of Chronic Diseases in China, 2025, 33(07): 509-14.
  14. Lv JC, Zhang LX. Prevalence and Disease Burden of Chronic Kidney Disease. Adv Exp Med Biol, 2019, 1165: 3-15.
  15. Banik S, Ghosh A. Prevalence of chronic kidney disease in Bangladesh: a systematic review and meta-analysis. Int Urol Nephrol, 2021, 53(4): 713-8.
  16. Talukdar R, Ajayan R, Gupt S, et al. Chronic Kidney Disease Prevalence in India: A Systematic Review and Meta-Analysis From Community-Based Representative Evidence Between 2011 to 2023. Nephrology (Carlton), 2025, 30(1): e14420.
  17. Liyanage T, Toyama T, Hockham C, et al. Prevalence of chronic kidney disease in Asia: a systematic review and analysis. BMJ Glob Health, 2022, 7(1).
  18. Yan JN, Liu L, Xia LY, etc Analysis of the Epidemic Status and Influencing Factors of Chronic Kidney Disease in Liaoning Province. Prevention and Control of Chronic Diseases in China, 2025, 33(06): 426-30.
  19. Tian HZ, Yan YL, Li H, et al Analysis of the Epidemic Status and Risk Factors of Chronic Kidney Disease in Henan Province. Modern Disease Prevention and Control, 2024, 35(06): 407-12.
  20. Chesnaye NC, Ortiz A, Zoccli C, et al. The impact of population ageing on the burden of chronic kidney disease. Nat Rev Nephrol, 2024, 20(9): 569-85.
  21. Hsu RK, Powe NR. Recent trends in the prevalence of chronic kidney disease: not the same old song. Curr Opin Nephrol Hypertens, 2017, 26(3): 187-96.
  22. Jha V, Al-ghamdi SMG, Li G, et al. Global Economic Burden Associated with Chronic Kidney Disease: A Pragmatic Review of Medical Costs for the Inside CKD Research Programme. Adv Ther, 2023, 40(10): 4405-20.
  23. Chesnaye NC, Carrero JJ, Hecking M, et al. Differences in the epidemiology, management and outcomes of kidney disease in men and women. Nat Rev Nephrol, 2024, 20(1): 7-20.
  24. Carrero JJ, Hecking M, Chesnaye NC, et al. Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease. Nat Rev Nephrol, 2018, 14(3): 151-64.
  25. Burnier M, Damianaki A. Hypertension as Cardiovascular Risk Factor in Chronic Kidney Disease. Circ Res, 2023, 132(8): 1050-63.
  26. Yan T, Yang S, Zhou X, et al. Chronic kidney disease among greenhouse workers and field workers in China. Chemosphere, 2022, 302: 134905.